Pharmacists may earn 1.00 CE Credits (0.10 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website). Your certificate will save on ASHP.org and will not be included in your myCME CME History.
This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).
Supported by an educational grant from Merck.
This activity will focus on current issues related to improving adult immunization in the ambulatory care setting. The faculty will address the key issues and provide practice pearls for physicians and pharmacists.
The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic.
This continuing education activity was planned to meet the needs of pharmacists and physicians in a variety of practice settings, including large and small health systems, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, physicians, clinical specialists, managers, leaders, and educators who are interested in improving adult immunization.
At the conclusion of this application-based educational activity, participants should be able to:
Describe data available for the 2015-16 influenza season and future vaccination implications
Evaluate frequent questions regarding vaccine recommendations and program implementation
Discuss updates from the Centers for Disease Control and Prevention for 2015 vaccine recommendations
Outline strategies to optimize vaccination rates in the adult population
Conflict Of Interest Disclosure Policy
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
Dr. Williams declares his spouse is a stockholder of GlaxoSmithKline plc.
David J. Weber, M.D., M.P.H., FIDSA, FSHEA Professor of Medicine and Pediatrics, UNC School of Medicine Professor of Epidemiology, UNC School of Public Health Associate Chief Medical Officer, UNC Health Care Medical Director, Hospital Epidemiology and Occupational Health University of North Carolina Chapel Hill, North Carolina
Dr. Weber declares he is a speaker and consultant for Merck and Pfizer, Inc.
Planners' and Managers' Disclosures
The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.
AMA PRA Category 1 Credit(s)TM
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
In order to receive credit, participants must complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
For information about the accreditation of this program, please contact firstname.lastname@example.org.